Saudi Aramco Warns Markets May Not Normalize Until 2027
Saudi Aramco’s CEO cautioned that oil markets may not normalize until 2027 as Strait of Hormuz disruptions persist, i...
Which Cheap Dividend Etf Is Best
This guide reviews criteria to determine the best cheap dividend ETF, including cost structure, track record, and diversification benefits for investors.
22,535 articles
We’re Bullish on SoundHound with Six Straight Earnings Beats
SoundHound AI reported its sixth consecutive earnings beat as revenue and AI platform demand accelerate. The LivePers...
Businesses Starting to Receive Their IEEPA Tariff Refunds
U.S. businesses are starting to receive their IEEPA tariff refunds, delivering relief to cash flows and inventory pla...
Half Health Advice Wrong—and Crypto Risk for Investors
Artificial intelligence can feel confident, but not all health advice it offers is accurate. This article explains th...
Nio Swapped Million Batteries Week: Is NIO Stock a Buy?
Nio just hit a landmark: a swapped million batteries week. The feat showcases its battery-swapping edge, but does it ...
Carvana Price Target Adjusted to $93 as Retail Volumes Hold
Barclays lowers Carvana's price target to $93 after a 5-for-1 stock split, while reaffirming an overweight stance as ...
Paysign Pays 2026 Earnings: Q1 Review and Outlook Today
Investors are watching Paysign as it tees up Q1 2026 earnings. This article breaks down what to expect, key metrics t...
Two Harbors Shareholder Sues to Block CCM Merger Vote
A Two Harbors shareholder files a federal lawsuit to block the CCM merger vote, alleging deceptive proxy disclosures ...
Small Caps Still Riding After Setback, Markets Eye Next
U.S. stocks wobbled Friday as the Russell 2000 slipped, but the small-cap rally remains a defining thread of 2026. In...
Foreign Holders of U.S. Debt May Bring Cash Home Soon
Top foreign owners of U.S. debt are signaling a possible shift toward domestic allocations, a move that could squeeze...
Buy, Hold or Sell Intel at the $100 Level Today, Analysts
Intel faces a pivotal moment as Q1 losses mount and cash burn deepens. Analysts and investors debate buy, hold sell i...
Hedge Fund Drops Million in Crinetics: Is It a Buy?
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status